Design and Evaluation of Personalized Free Trials
Free trial promotions, where users are given a limited time to try the product for free, are a commonly used customer acquisition strategy in the Software as a Service (SaaS) industry. We examine how trial length affect users' responsiveness, and seek to quantify the gains from personalizing the length of the free trial promotions. Our data come from a large-scale field experiment conducted by a leading SaaS firm, where new users were randomly assigned to 7, 14, or 30 days of free trial. First, we show that the 7-day trial to all consumers is the best uniform policy, with a 5.59% increase in subscriptions. Next, we develop a three-pronged framework for personalized policy design and evaluation. Using our framework, we develop seven personalized targeting policies based on linear regression, lasso, CART, random forest, XGBoost, causal tree, and causal forest, and evaluate their performances using the Inverse Propensity Score (IPS) estimator. We find that the personalized policy based on lasso performs the best, followed by the one based on XGBoost. In contrast, policies based on causal tree and causal forest perform poorly. We then link a method's effectiveness in designing policy with its ability to personalize the treatment sufficiently without over-fitting (i.e., capture spurious heterogeneity). Next, we segment consumers based on their optimal trial length and derive some substantive insights on the drivers of user behavior in this context. Finally, we show that policies designed to maximize short-run conversions also perform well on long-run outcomes such as consumer loyalty and profitability.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Machine Learning for Health: Personalized Models for Forecasting of Alzheimer Disease Progression
In this thesis the aim is to work on optimizing the modern machine learning models for personalized forecasting of Alzheimer Disease (AD) Progression from clinical trial data. The data comes from the TADPOLE challenge, w…
BIG-bench Machine LearningGaussian ProcessesThe Future will be Different than Today: Model Evaluation Considerations when Developing Translational Clinical Biomarker
Finding translational biomarkers stands center stage of the future of personalized medicine in healthcare. We observed notable challenges in identifying robust biomarkers as some with great performance in one scenario of…
Personalization of Large Foundation Models for Health Interventions
Large foundation models (LFMs) transform healthcare AI in prevention, diagnostics, and treatment. However, whether LFMs can provide truly personalized treatment recommendations remains an open question. Recent research h…
Causal InferenceWho Are the Best Adopters? User Selection Model for Free Trial Item Promotion
With the increasingly fierce market competition, offering a free trial has become a potent stimuli strategy to promote products and attract users. By providing users with opportunities to experience goods without charge,…
Marketingreinforcement-learningReinforcement LearningReinforcement Learning (RL)TREEMENT: Interpretable Patient-Trial Matching via Personalized Dynamic Tree-Based Memory Network
Clinical trials are critical for drug development but often suffer from expensive and inefficient patient recruitment. In recent years, machine learning models have been proposed for speeding up patient recruitment via a…